Hosier Gregory W, McGregor Thomas, Beiko Darren, Tasian Gregory E, Booth Christopher, Whitehead Marlo, Siemens D Robert
Department of Urology, Queen's University, Kingston, ON.
Department of Pediatric Urology, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Can Urol Assoc J. 2020 Aug;14(8):237-244. doi: 10.5489/cuaj.6796.
Adolescents and young adults are a vulnerable patient population for development of substance use disorder. However, the long-term impact of opioid prescribing in young adult patients with renal colic is not known. Our objective was to describe rates of opioid prescription and identify risk factors for persistent opioid use in patients age 25 years or younger with renal colic from kidney stones.
Using previously validated, linked administrative databases, we performed a population-based, retrospective cohort study of opioid-naive patients age 25 years or younger with renal colic between July 1, 2013 and September 30, 2017 in Ontario. All family practitioner, urgent care, and specialist visits in the province were captured. Our primary outcome was persistent opioid use, defined as filling a prescription for an opioid between 91 and 180 days after initial visit. Ontario uses a narcotic monitoring system, which captures all opioids dispensed in the province.
Of the 6962 patients identified, 56% were prescribed an opioid at presentation and 34% of those were dispensed more than 200 oral morphine equivalents. There was persistent opioid use in 313 (8.1%) patients who filled an initial opioid prescription. In adjusted analysis, those prescribed an opioid initially had a significantly higher risk of persistent opioid use (odds ratio [OR] 1.85; 95% confidence interval [CI] 1.50-2.29) and opioid overdose (OR 3.45; 1.08-11.04). There was a dose-dependent increase in risk of persistent opioid use with escalating initial opioid dose. History of mental illness (OR 1.32; 1.02-1.71) and need for surgery (OR 1.71; 1.24-2.34) were also associated with persistent opioid use.
Among patients with kidney stones age 25 years or younger, filling an opioid prescription after presentation is associated with an increased risk of persistent opioid use 3-6 months later and a higher risk of serious long-term complications, such as opioid overdose.
青少年和青年是药物使用障碍发展的脆弱患者群体。然而,阿片类药物处方对患有肾绞痛的年轻成年患者的长期影响尚不清楚。我们的目标是描述阿片类药物处方率,并确定25岁及以下肾结石所致肾绞痛患者持续使用阿片类药物的风险因素。
利用先前经过验证的关联行政数据库,我们对2013年7月1日至2017年9月30日安大略省25岁及以下未使用过阿片类药物的肾绞痛患者进行了一项基于人群的回顾性队列研究。该省所有家庭医生、紧急护理和专科就诊情况均被记录。我们的主要结局是持续使用阿片类药物,定义为在初次就诊后91至180天内开具阿片类药物处方。安大略省使用麻醉品监测系统,该系统记录该省分发的所有阿片类药物。
在确定的6962名患者中,56%在就诊时被开具了阿片类药物处方,其中34%的患者被分发了超过200口服吗啡当量。在最初开具阿片类药物处方的313名(8.1%)患者中存在持续使用阿片类药物的情况。在多因素分析中,最初开具阿片类药物处方的患者持续使用阿片类药物的风险显著更高(比值比[OR]1.85;95%置信区间[CI]1.50-2.29)以及阿片类药物过量风险(OR 3.45;1.08-11.04)。随着初始阿片类药物剂量增加,持续使用阿片类药物的风险呈剂量依赖性增加。精神疾病史(OR 1.32;1.02-1.71)和手术需求(OR 1.71;1.24-2.34)也与持续使用阿片类药物有关。
在25岁及以下的肾结石患者中,就诊后开具阿片类药物处方与3至6个月后持续使用阿片类药物的风险增加以及严重长期并发症(如阿片类药物过量)的风险较高有关。